In the meta-analysis, the PNPLA3 rs738409 C>G polymorphism was found to be significantly associated with an increased risk of HCC, and the PNPLA3 rs738409 polymorphism may be a potential biomarker for HCC in whites 67, 68. Here, PNPLA3 is linked to hepatocellular carcinoma.